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The main goal of this thesis is to evaluate whether fetoplacental 
exosomes, endothelial exosomes mainly, have a role in the modulation 
of changes associated to fetoplacental endothelial dysfunction in 
GDM. In this thesis, we used human umbilical vein endothelial cells 
(HUVECs) from healthy pregnant women incubated with high levels 
of D-glucose as a model for HUVECs from patients with GDM. 
In chapter 3, we first evaluated the effects of high glucose on HUVECs 
endothelial function and activation. We characterized endothelial 
function by measuring endothelial cell migration with the wound 
healing assay and we measured expression of eNOS, hCAT-1 and 
VEGF. As a measure for endothelial cell activation we measured ICAM-
1 expression. We next evaluated whether high levels of D-glucose 
increased endothelial exosomal production and whether the exosomes 
derived from HUVECs exposed to high levels of D-glucose modulate 
the changes in endothelial function and activation induced by high 
D-glucose. 
Chapter 4 describes the possible role of the proinflammatory TNF-α, 
in a hyperglycemic environment, in the fetoplacental endothelial 
dysfunction in GDM. Therefore HUVECs were coincubated with high 
levels of D-glucose and TNF- and endothelial function and activation 
was studied. We then evaluated the role of TNF-α and high levels of 
D-glucose on the production of endothelial exosomes and whether 
these exosomes modulate endothelial dysfunction and activation 
induced by TNF-α and high levels of D-glucose.
 
In Chapter 5 we test the hypothesis that monocytes, as prominent 
producers of TNF-α, communicate with endothelial cells via exosomes 
to induce endothelial cell activation under hyperglycemic conditions. 
In this chapter, we use monomac-6 (MM6) cells as a model for 
human mature monocytes. We first tested the effect of high levels of 
D-glucose on MM6 cell activation and tested the role of exosomes 
in this activation. Then we tested whether exosomes from MM6 
incubated with high levels of D-glucose induced HUVECs activation 
and whether exosomes from HUVECs incubated with high levels of 
D-glucose induced activation of MM6. Finally we tested whether a 
mix of exosomes from MM6 and HUVEC incubated with high levels of 
D-glucose activated MM6 and HUVECs. 
Since chapters 3, 4 and 5 showed a role for exosomes in inducing 
endothelial dysfunction and activation in high glucose incubated 
HUVECs, a model for HUVECs from GDM, we hypothesized that 
endothelial dysfunction in HUVECs from GDM could also be induced 
by exosomes. This hypothesis was tested in the final chapter, Chapter 
6. To determine whether these exosomes are involved in the induction 
of fetoplacental endothelial dysfunction in GDM, we exposed HUVECs 
from healthy pregnant individuals to endothelial exosomes derived 




of L-Arginine transport via hCAT-1 in HUVECs, on hCAT-1 and eNOS 
expression as well as on NO production. We also evaluated whether 
these changes are mediated by MAPK or AKT signaling pathways.
In Chapter 7, the results of this thesis are discussed.
